Brynovin Solution
Product Images NDC 24338-017

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Brynovin (NDC 24338-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This is a medical chart detailing different treatment options for patients with diabetes, including the use of Placebo, Metformin, and Sitagliptin at various dosages. The chart also mentions adjusting for prior antihyperglycemic therapy and baseline values when analyzing data.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This text appears to provide information on the LS Mean Change from Baseline for a study involving Sitagliptin 100 mg and Glipizide over a 24-week period. The values listed show a decrease over time, with measurements at weeks 12, 18, and 24.*
FDA Label Image

Sitagliptin Bottle Label (Sitagliptin Bottle Label)

Sitagliptin Bottle Label (Sitagliptin Bottle Label)
This is a medication label providing important instructions for storing and using an oral solution containing sitagliptin hydrochloride. It advises keeping the medication away from children, storing in a refrigerated environment between 2°C - 8°C (36°F - 46°F) to protect from light and heat. Each 1 mL dose contains 27.24 mg of sitagliptin hydrochloride. The label also mentions the expiration date and advises to see the prescribing information for recommended dosage. It is for oral administration only.*
FDA Label Image

Sitagliptin Carton Label (Sitagliptin Carton Label)

Sitagliptin Carton Label (Sitagliptin Carton Label)
This is information about Brynovin (sitagliptin) oral solution, with NDC code 2433801701. It includes instructions for use, storage (refrigeration), equivalent dosage proportions, and a reminder to keep medications out of children's reach. The text also advises to discard any unused portion of the solution after 90 days of opening.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.